Literature DB >> 36134862

Primary Giant Mediastinal Hydatid Cyst Extending to the Superior Thoracic Inlet.

Yener Aydin1, Ali Bilal Ulas1, Atilla Eroglu1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 36134862      PMCID: PMC9491231          DOI: 10.1590/0037-8682-0176-2022

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   2.141


× No keyword cloud information.
A 57-year-old woman presented to our hospital with chest and shoulder pain. A giant mediastinal cystic lesion extending from the apex to the inferior perihilar area on the right hemithorax was detected radiologically. The patient underwent video-assisted thoracoscopic surgery. The intraoperative lesion was identified as a hydatid cyst and resected thoracoscopically (Figure 1).
FIGURE 1:

(A) Axial, (B, C) coronal, and (D) sagittal thoracic computed tomography sections show a mediastinal cystic lesion of approximately 10 x 4 cm (arrowheads) extending from the apex to the perihilar area in the right hemithorax. (E, F) The lesion was diagnosed intraoperatively as a hydatid cyst (arrow, laminated membrane; circle, cyst cavity).

Hydatid cysts caused by metacestode forms of Echinococcus granulosus are commonly located in the liver and lungs. The mediastinal involvement rate is 0.61%, and primary mediastinal localization is less common . Symptoms depend on the cyst size, location, and compression on adjacent structures, such as the esophagus, aorta, trachea, vena cava, and phrenic nerve , . Although primary giant mediastinal hydatid cysts are rare, they should be considered in the differential diagnosis of all mediastinal lesions.
  2 in total

1.  Mediastinal calcified hydatid cyst.

Authors:  Yener Aydin; Nesrin Gursan; Atila Turkyilmaz; Atilla Eroglu
Journal:  Ann Thorac Surg       Date:  2011-10       Impact factor: 4.330

2.  Surgical treatment of mediastinal cysts: report on 29 cases.

Authors:  Y Aydin; H Ogul; A Turkyilmaz; A Eroglu
Journal:  Acta Chir Belg       Date:  2012 Jul-Aug       Impact factor: 1.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.